Aerpio Pharmaceuticals Inc. (NASDAQ: ARPO) open the trading on September 15, 2020, with great promise as it jumped 5.08% to $1.24. During the day, the stock rose to $1.34 and sunk to $1.17 before settling in for the price of $1.18 at the close. Taking a more long-term approach, ARPO posted a 52-week range of $0.42-$1.90.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -87.10%. This publicly-traded company’s shares outstanding now amounts to $40.59 million, simultaneously with a float of $34.44 million. The organization now has a market capitalization sitting at $52.99 million. At the time of writing, stock’s 50-day Moving Average stood at $1.3970, while the 200-day Moving Average is $0.8972.
Aerpio Pharmaceuticals Inc. (ARPO) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Aerpio Pharmaceuticals Inc.’s current insider ownership accounts for 24.32%, in contrast to 27.30% institutional ownership.
Aerpio Pharmaceuticals Inc. (ARPO) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 12/30/2019 suggests? It has posted -$0.11 earnings per share (EPS) beating the forecaster’s viewpoint (set at -$0.12) by $0.01. This company achieved a return on equity of -48.89. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Aerpio Pharmaceuticals Inc.’s EPS decrease for this current 12-month fiscal period is -87.10% and is forecasted to reach -0.63 in the upcoming year.
Aerpio Pharmaceuticals Inc. (NASDAQ: ARPO) Trading Performance Indicators
Let’s observe the current performance indicators for Aerpio Pharmaceuticals Inc. (ARPO). It’s Quick Ratio in the last reported quarter now stands at 14.60. The Stock has managed to achieve an average true range (ATR) of 0.15. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.53.
In the same vein, ARPO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.09, a figure that is expected to reach -0.14 in the next quarter, and analysts are predicting that it will be -0.63 at the market close of one year from today.
Technical Analysis of Aerpio Pharmaceuticals Inc. (ARPO)
[Aerpio Pharmaceuticals Inc., ARPO] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 47.13% While, its Average True Range was 0.1439.
Raw Stochastic average of Aerpio Pharmaceuticals Inc. (ARPO) in the period of the previous 100 days is set at 50.56%, which indicates a major rise in contrast to 37.04% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 50.82% that was lower than 102.00% volatility it exhibited in the past 100-days period.